# Tear-Based Oxidative Stress Biomarkers in Primary and Sarcoidosis-Associated Dry Eye Disease

**Authors:** Calina-Anda Sandu, Vlad Constantin Donica, Ioana-Miruna Balmus, Ioana Madalina Bilha, Cosmin Victor Ganea, Ioana Alexandra Sandu, Anisia Iuliana Alexa, Alexandra Lori Donica, Valentina Esanu, Alin Ciobica, Camelia Margareta Bogdanici

PMC · DOI: 10.3390/ijms27042071 · International Journal of Molecular Sciences · 2026-02-23

## TL;DR

This study shows that different types of dry eye disease have unique tear-based oxidative stress profiles, which could help in better diagnosing and understanding the condition.

## Contribution

The study identifies distinct oxidative stress biomarkers in primary and sarcoidosis-associated dry eye disease.

## Key findings

- Primary DED is marked by increased lipid peroxidation, while S-DED shows impaired antioxidant defenses.
- Tear collection methods significantly affect oxidative stress marker measurements.
- Oxidative stress markers correlate with clinical tear film dysfunction.

## Abstract

Dry eye disease (DED) has increasingly been linked to oxidative stress; however, the specific redox mechanisms underlying different clinical phenotypes remain incompletely understood. This study aimed to evaluate tear film oxidative stress profiles in patients with primary DED and sarcoidosis-associated DED (S-DED) by assessing lipid peroxidation, antioxidant enzyme activity, and total tear protein content, and to explore their relationship with clinical tear film dysfunction. Tear samples were analyzed for superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, as well as for malondialdehyde (MDA) and total protein levels, alongside standard clinical tests of tear film stability and secretion. Both DED groups exhibited significant oxidative alterations compared to controls, but with distinct redox signatures. Primary DED was characterized by markedly increased tear MDA levels, indicating predominant lipid peroxidation, whereas S-DED showed a more pronounced impairment of antioxidant defense, reflected by preserved or increased SOD activity in the context of significantly reduced GPx activity. Total tear protein levels were reduced in both groups, with evidence suggesting qualitative protein alterations in S-DED. The tear collection method significantly influenced the measured levels of several oxidative stress markers, underscoring the importance of sampling technique when interpreting tear-based redox profiles. Oxidative stress markers correlated with clinical measures of tear film dysfunction, supporting their physiological relevance. These findings demonstrate that DED encompasses heterogeneous oxidative stress mechanisms and that sarcoidosis acts as a modifier of ocular surface redox homeostasis. Distinct tear-based redox profiles differentiate primary from sarcoidosis-associated dry eye, highlighting the potential value of oxidative biomarkers for phenotyping DED beyond tear deficiency alone.

## Linked entities

- **Proteins:** GPX2 (glutathione peroxidase 2)
- **Chemicals:** malondialdehyde (PubChem CID 10964)
- **Diseases:** sarcoidosis (MONDO:0008399)

## Full-text entities

- **Genes:** LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, mucin [NCBI Gene 100508689], AATF (apoptosis antagonizing transcription factor) [NCBI Gene 26574] {aka BFR2, CHE-1, CHE1, DED}
- **Diseases:** epithelial injury (MESH:D009375), fibrosis (MESH:D005355), injury to (MESH:D014947), inflammation (MESH:D007249), corneal disorders (MESH:D003316), aqueous deficiency (MESH:D007153), Ocular sarcoidosis (MESH:D012507), keratoconus (MESH:D007640), Primary (MESH:D010538), Sjogren (MESH:D012859), ocular surface disease (MESH:D010534), atrophy (MESH:D001284), DED (MESH:D015352), depression (MESH:D003866), anterior segment infection (MESH:C537775), CSCR (MESH:D056833), meibomian gland atrophy (MESH:D000080343), granulomas (MESH:D006099), orbital disease (MESH:D009916), lacrimal gland impairment (MESH:C562407), gland (MESH:D000307), ocular diseases (MESH:D005128), clinical (MESH:D000075902), serous retinal detachment (MESH:D012163), tear deficiency (MESH:D012167), Functional Impairment (MESH:D003072), tissue injury (MESH:D017695)
- **Chemicals:** S (MESH:D013455), superoxide (MESH:D013481), PBS (-), hydrogen peroxide (MESH:D006861), Polyunsaturated fatty acids (MESH:D005231), NADPH (MESH:D009249), peroxide (MESH:D010545), MDA (MESH:D008315), Coomassie Brilliant Blue (MESH:C004692), glutathione (MESH:D005978), tetrazolium salt (MESH:D013778), water (MESH:D014867), TBA (MESH:C029684), Lipid (MESH:D008055), 4-hydroxynonenal (MESH:C027576), aldehyde (MESH:D000447), ROS (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940756/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940756/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940756/full.md

---
Source: https://tomesphere.com/paper/PMC12940756